TTX Stock Chart & Stats
AU$5.11
--
Market closed
AU$5.11
--
Day’s Range― - ―
52-Week RangeAU$3.09 - AU$8.08
Previous CloseN/A
VolumeN/A
Average Volume (3M)27.38K
Market Cap
AU$314.11M
Enterprise ValueAU$294.82
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.60
Next Earnings
Mar 01, 2027EPS Estimate
-0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding53,058,310
10 Day Avg. Volume24,525
30 Day Avg. Volume27,377
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$6.95Price Target Upside35.91% Upside
Rating ConsensusHold
Number of Analyst Covering2
EPS Forecast (FY)-0.16
Revenue Forecast (FY)AU$7.85M
Tetratherix Limited News
TTX FAQ
What was Tetratherix Limited’s price range in the past 12 months?
Tetratherix Limited lowest share price was AU$3.09 and its highest was AU$8.08 in the past 12 months.
What is Tetratherix Limited’s market cap?
Tetratherix Limited’s market cap is AU$314.11M.
When is Tetratherix Limited’s upcoming earnings report date?
Tetratherix Limited’s upcoming earnings report date is Mar 01, 2027 which is in 151 days.
How were Tetratherix Limited’s earnings last quarter?
Tetratherix Limited released its earnings results on Aug 19, 2026. The company reported -AU$0.092 earnings per share for the quarter, missing the consensus estimate of -AU$0.081 by -AU$0.011.
Is Tetratherix Limited overvalued?
According to Wall Street analysts Tetratherix Limited’s price is currently Undervalued.
Does Tetratherix Limited pay dividends?
Tetratherix Limited does not currently pay dividends.
What is Tetratherix Limited’s EPS estimate?
Tetratherix Limited’s EPS estimate is -0.05.
How many shares outstanding does Tetratherix Limited have?
Tetratherix Limited has 53,058,310 shares outstanding.
What happened to Tetratherix Limited’s price movement after its last earnings report?
Tetratherix Limited reported an EPS of -AU$0.092 in its last earnings report, missing expectations of -AU$0.081. Following the earnings report the stock price went up 4.274%.
Which hedge fund is a major shareholder of Tetratherix Limited?
Currently, no hedge funds are holding shares in AU:TTX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Tetratherix Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
AU$6.95 (35.91% Upside)
AU$6.95 (35.91% Upside)
Blogger Sentiment
Bullish
AU:TTX Sentiment 100%
Sector Average ―
Sector Average ―
Technicals
SMA
Positive
20 days / 200 days
Momentum
42.99%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
67.02%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Tetratherix Limited
Established in 2015 and headquartered in Alexandria, Australia, Tetratherix Ltd. operates in the biomaterials and regenerative medicine sectors across both domestic and international markets. The company develops and supplies products using its proprietary Tetramatrix platform technology, with a focus on applications including bone regeneration, tissue spacing, and advanced tissue healing.
TTX Stock 12 Month Forecast
Average Price Target
AU$6.95
▲(35.91% Upside)
Technical Analysis
Osteopore Ltd.
―
Dimerix Limited
―
Race Oncology Ltd.
―
Cyclopharm Limited
―
Medical Developments International Limited
―






